Indiana University – Purdue University Indianapolis

Anastrozole has an Association between Degree of Estrogen Suppression and Outcomes in Early Breast Cancer and is a Ligand for Estrogen Receptor α (2020) Ingle JN, Cairns J, Suman VJ, Shepherd LE, Fasching P, Hoskin TL, Singh RJ, et al. Journal article Effect of lattice mismatch and shell thickness on strain in core@shell nanocrystals (2020) Gamler JT, Leonardi A, Sang X, Koczkur KM, Unocic RR, Engel M, Skrabalak SE Journal article Immunotherapy for urothelial cancer: from the diagnostic pathologist's point of view (2020) Cimadamore A, Scarpelli M, Massari F, Eckstein M, Gevaert T, Cheng L, Lopez-Beltran A, Montironi R Journal article, Editorial Report From the International Society of Urological Pathology (ISUP) Consultation Conference On Molecular Pathology Of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer: Progress and Challenges. (2020) Warrick J, Knowles MA, Yves A, Van Der Kwast T, Grignon DJ, Kristiansen G, Egevad L, et al. Journal article Report from the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer: Progress and Challenges (2020) Warrick JI, Knowles MA, Yves A, Van Der Kwast T, Grignon DJ, Kristiansen G, Egevad L, et al. Journal article, Report Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded (2020) Samaratunga H, Delahunt B, Egevad L, Srigley JR, Billis A, Bostwick DG, Camparo P, et al. Journal article PD-L1 assessment in urothelial carcinoma: a practical approach (2019) Eckstein M, Cimadamore A, Hartmann A, Lopez-Beltran A, Cheng L, Scarpelli M, Montironi R, Gevaert T Journal article, Review article Predictive biomarkers for immunotherapy in the treatment of advanced urothelial carcinoma: Where we stand and where we go (2019) Gevaert T, Cimadamore A, Eckstein M, Scarpelli M, Lopez-Beltran A, Cheng L, Montironi R Journal article, Review article Renal Denervation Update From the International Sympathetic Nervous System Summit: JACC State-of-the-Art Review (2019) Kiuchi MG, Esler MD, Fink GD, Osborn JW, Banek CT, Böhm M, Denton KM, et al. Journal article, Review article Author Correction: Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signaling (Nature Metabolism, (2019), 1, 1, (111-124), 10.1038/s42255-018-0005-8) (2019) Rauner M, Baschant U, Roetto A, Pellegrino RM, Rother S, Salbach-Hirsch J, Weidner H, et al. Journal article, Erratum